Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 4, 2016, Pages 750-757

  Ferreira, Ana R ^a   Magalhães, Ana C ^a   Camões, Fátima ^a   Gouveia, Ana ^a   Vieira, Marta ^a   Kagan, Jonathan C ^b   Ribeiro, Daniela ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Hepatitis C virus; MAVS; NS3 4A; Peroxisomes

Indexed keywords

HEPACIVIRIN; INTERFERON REGULATORY FACTOR 1; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; NONSTRUCTURAL PROTEIN 4A; PEPTIDES AND PROTEINS; PEROXISOMAL INTEGRAL MEMBRANE PROTEIN 70; PROTEIN HYDROLYSATE; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIPERIN; IPS-1 PROTEIN, MOUSE; NS3 PROTEIN, HEPATITIS C VIRUS; NS4A PROTEIN, FLAVIVIRUS; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRAL PROTEIN;

ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; GENE EXPRESSION; HEPATITIS C VIRUS; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; PEROXISOME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL LINE; FIBROBLAST; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; HEPACIVIRUS; HUMAN; IMMUNE EVASION; IMMUNOLOGY; KINETICS; MITOCHONDRION; MOUSE; MUTATION; SIGNAL TRANSDUCTION; ULTRASTRUCTURE; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; DEAD BOX PROTEIN 58; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HEPACIVIRUS; HUMANS; IMMUNE EVASION; KINETICS; MICE; MITOCHONDRIA; MUTATION; PEROXISOMES; PROTEOLYSIS; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84961218027     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12801     Document Type: Article

References (34)

1. Chevaliez S, Pawlotsky J-M. HCV Genome and Life Cycle. In: Tan S, editor. Hepatitis C Viruses Genomes and Molecular Biology. Norfolk (UK): Horizon Bioscience; 2006 pp. 5-47.
2. Sarrazin C, Hézode C, Zeuzem S, et al. Antiviral strategies in hepatitis C virus infection. J Hepatol. 2012; 56: S88-100.
3. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004; 5: 730-7.
4. Cao X, Ding Q, Lu J, et al. MDA5 plays a critical role in interferon response during hepatitis C virus infection. J Hepatol. 2014; 62: 771-8.
5. Saito T, Owen DM, Jiang F, et al. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature. 2008; 454: 523-7.
6. Seth RB, Sun L, Ea C-K, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005; 122: 669-82.
7. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 2005; 6: 981-8.
8. Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 2005; 437: 1167-72.
9. Xu L-G, Wang Y-Y, Han K-J, et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell. 2005; 19: 727-40.
10. Moore CB, Ting JP-Y. Regulation of mitochondrial antiviral signaling pathways. Immunity. 2008; 28: 735-9.
11. Li X-D, Sun L, Seth RB, et al. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA. 2005; 102: 17717-22.
12. Garaigorta U, Chisari FV. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phos-phorylation. Cell Host Microbe. 2009; 6: 513-22.
13. Gokhale NS, Vazquez C, Horner SM. Hepatitis C virus. Strategies to evade antiviral responses. Future Virol. 2014; 9: 1061-75.
14. Petrovic D, Stamataki Z, Dempsey E, et al. Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion. Hepatology. 2011; 53: 1846-53.
15. Ding Q, Cao X, Lu J, et al. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J Hepatol. 2013; 59: 52-8.
16. Chen Y, Chen J, Wang H, et al. HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog. 2013; 9: e1003248.
17. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol. 2007; 5: 453-63.
18. Foy E, Li K, Wang C, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science. 2003; 300: 1145-8.
19. Morikawa K, Lange CM, Gouttenoire J, et al. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat. 2011; 18: 305-15.
20. He Y, Weng L, Li R, et al. The N-terminal helix α(0) of hepatitis C virus NS3 protein dictates the subcellular localization and stability of NS3/NS4A complex. Virology. 2012; 422: 214-23.
21. Hijikata M, Mizushima H, Tanji Y, et al. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci USA. 1993; 90: 10773-7.
22. Dixit E, Boulant S, Zhang Y, et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell. 2010; 141: 668-81.
23. Horner SM, Liu HM, Park HS, et al. Mitochondial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci USA. 2011; 108: 14590-5.
24. Islinger M, Grille S, Fahimi HD, et al. The peroxisome: an update on mysteries. Histochem Cell Biol. 2012; 137: 547-74.
25. Schrader M, Fahimi HD. Peroxisomes and oxidative stress. Biochim Biophys Acta. 2006; 1763: 1755-66.
26. Schrader M, Fahimi HD. The peroxisome: still a mysterious organelle. Histochem Cell Biol. 2008; 129: 421-40.
27. Ribeiro D, Castro I, Fahimi HD, et al. Peroxisome morphology in pathology. Histhol Histhopathol. 2012; 27: 661-76.
28. Odendall C, Dixit E, Stavru F, et al. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol. 2014; 15: 717-26.
29. Breiman A, Vitour D, Vilasco M, et al. A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells. J Gen Virol. 2006; 87: 3587-98.
30. Tanji Y, Hijikata M, Satoh S, et al. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol. 1995; 69: 1575-81.
31. Wölk B, Sansonno D, Kräusslich HG, et al. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol. 2000; 74: 2293-304.
32. Fransen M, Wylin T, Brees C, et al. Human pex19p binds peroxisomal integral membrane proteins at regions distinct from their sorting sequences. Mol Cell Biol. 2001; 21: 4413-24.
33. Valença I, Pértega-Gomes N, Vizcaino JR, et al. Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer. J Cell Mol Med. 2015; 19: 723-33.
34. Bolte S, Cordelières FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006; 224: 213-32.